← Back
$TMCI All transactions

TREACE MEDICAL CONCEPTS, INC.

A

$ Value

$0

Shares

262,500

Price

$0

Filed

Jan 23

Insider

Name

Scanlan Sean F.

Title

Chief Innovation Officer

CIK

0001856371

Roles

Officer

Transaction Details

Transaction Date

2026-01-22

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

689,599

Footnotes

Includes 283,948 restricted stock units. | Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2027 and the last installment vesting on January 22, 2030; subject to Reporting Person's providing continued service to Issuer through each vesting date. | Includes 511,291 restricted stock units | The stock option vested in equal annual installments over 4 years, commencing on January 26, 2016 with the last installment vesting on January 26, 2020.

Filing Info

Accession No.

0001193125-26-021450

Form Type

4

Issuer CIK

0001630627

Scanlan Sean F.'s History

Date Ticker Type Value
2026-03-10 TMCI F $0
2026-03-08 TMCI F $0
2026-02-10 TMCI M $18K
2026-02-10 TMCI M $0
2026-01-22 TMCI A $0
2026-01-21 TMCI M $39K
2026-01-21 TMCI M $0
2025-10-24 TMCI F $0
2025-08-09 TMCI F $0
2025-07-18 TMCI M $24K

Other Insiders at TMCI (90d)

Insider Bought Sold Last
Hair Mark
Chief Financial Officer
2026-04-17
Scanlan Sean F.
Chief Innovation Officer
2026-03-10
Treace John T.
Chief Executive Officer
2026-03-10
Elder Scot Michael
Chief Legl & Comp Off, CorpSec
2026-03-10